FDA clears IND for phase II study of NRD135S-E1 in painful diabetic peripheral neuropathy June 25, 2020
Seelos presents final phase I safety data for SLS-002 and additional clinical development plans June 25, 2020
Selective inhibition of GSK-3alpha ameliorates the phenotype of a mouse model of fragile X syndrome June 22, 2020
RSS